17-31181795-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_001042492.3(NF1):c.730+10C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000097 in 1,546,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000092 ( 0 hom. )
Consequence
NF1
NM_001042492.3 intron
NM_001042492.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0280
Publications
0 publications found
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
- neurofibromatosis type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- neurofibromatosis-Noonan syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, PanelApp Australia
- Moyamoya diseaseInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 17-31181795-C-T is Benign according to our data. Variant chr17-31181795-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 412976.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 13 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NF1 | NM_001042492.3 | c.730+10C>T | intron_variant | Intron 7 of 57 | ENST00000358273.9 | NP_001035957.1 | ||
| NF1 | NM_000267.4 | c.730+10C>T | intron_variant | Intron 7 of 56 | NP_000258.1 | |||
| NF1 | NM_001128147.3 | c.730+10C>T | intron_variant | Intron 7 of 14 | NP_001121619.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000144 AC: 2AN: 138454Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
138454
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000923 AC: 13AN: 1408504Hom.: 0 Cov.: 27 AF XY: 0.00000854 AC XY: 6AN XY: 702572 show subpopulations
GnomAD4 exome
AF:
AC:
13
AN:
1408504
Hom.:
Cov.:
27
AF XY:
AC XY:
6
AN XY:
702572
show subpopulations
African (AFR)
AF:
AC:
1
AN:
32556
American (AMR)
AF:
AC:
0
AN:
43942
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25620
East Asian (EAS)
AF:
AC:
0
AN:
39352
South Asian (SAS)
AF:
AC:
1
AN:
82354
European-Finnish (FIN)
AF:
AC:
0
AN:
53246
Middle Eastern (MID)
AF:
AC:
0
AN:
5232
European-Non Finnish (NFE)
AF:
AC:
11
AN:
1067568
Other (OTH)
AF:
AC:
0
AN:
58634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000144 AC: 2AN: 138454Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 66300 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
138454
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
66300
show subpopulations
African (AFR)
AF:
AC:
0
AN:
39726
American (AMR)
AF:
AC:
0
AN:
12712
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3250
East Asian (EAS)
AF:
AC:
0
AN:
4708
South Asian (SAS)
AF:
AC:
0
AN:
4172
European-Finnish (FIN)
AF:
AC:
0
AN:
7616
Middle Eastern (MID)
AF:
AC:
0
AN:
272
European-Non Finnish (NFE)
AF:
AC:
2
AN:
63308
Other (OTH)
AF:
AC:
0
AN:
1824
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurofibromatosis, type 1 Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.